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The carboxy-terminal region of translational initiation factor IF2 is a common region to the three active forms of the factor (a, /I and y) but its 
function is still unknown. We report here that this region of IF2 carries at least one domain which is homologous to the N-terminal and middle 
part of the c1 repressor of lambda phage. The IF2 homologous domain harbors functionally important features of the lambda repressor, e.g. the 
helix-turn-helix motif and some of the residues essential for the structure of the hydrophobic core of the repressor. This homologous domain of 
IF2 was fused to the /3-galactosidase protein. The hybrid protein, as well as IF2 itself, shows a consistent DNA binding activity in nitrocellulose 
filtration assays but does not display the specificity of the c1 repressor for the PR operator. The implication of this domain in the transcriptional 
activity of IF2, reported by others, is discussed. 
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1. INTRODUCTION 
IF2 is one of the three translational factors involved 
in the formation of the first peptide bond in Escherichia 
coli. IF2 promotes the binding of Met-tRNAr”“’ to the 
30 S ribosomal subunit leading to the formation of the 
30 S initiation complex. It is also responsible for GTP 
hydrolysis during elaboration of the 70 S initiation com- 
plex (for reviews, see [14]). 
Only recently, molecular studies were performed to 
identify the different regions of fMet-tRNAr”“’ and 
rRNA protected by IF2 against chemical and enzymatic 
modifications [ 12,131. However, molecular analysis of 
the factor itself and of the domains implicated in the 
different processes have to be strengthened, although 
initial attempts to crystallize IF2 have failed [4]. 
Furthermore, IF2 is suspected to participate to two 
cellular processes unrelated to protein synthesis, respec- 
tively, activation of transcription [5] and translocation 
of proteins across the bacterial membrane [6]. 
IF2 is present as two forms in the cell: 01, a full length 
protein of 890 amino acids, and /? lacking the first 157 
N-terminal amino acids of the 01 form. These two forms 
result from the use of two independent and in-phase 
translational start sites on IF2 mRNA [7-lo]. A smaller 
form, y, lacking the first 269 amino acids of IF2a, arises 
artefactually by limited proteolysis during the purifica- 
tion process. The three forms a, p, y are able to catalyze 
in vitro reactions such as GTP hydrolysis or dipeptide 
synthesis [111. 
The IF2a protein sequence deduced from the in@ 
gene [14] reveals at least three structural domains: the 
N-terminal part (residues 1-214) which is characterized 
by an unusual amino acid composition, then the central 
part of IF2 molecule (residues 350-600) which shows 
extensive homologies with well-known G proteins such 
as EF-Tu [11,14-161, and the C-terminal part of IF2 
(residues 600-890). The latter has so far been less sub- 
ject to investigations compared to the two other do- 
mains, and it did not seem to carry any particular struc- 
tural features. However, like the central G domain, this 
segment is common to the three forms tc, p, y and en- 
compasses aregion possibly implicated in one or several 
functions of the factor. 
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In the present work, we reinvestigate the role of the 
C-terminal segment of IF2. We found that it displays an 
important sequence homology to the middle and N- 
terminal domains of the c1 repressor of phage lambda, 
an extensively studied DNA binding protein. This do- 
main corresponds to a region of the c1 repressor harbor- 
ing important functional and structural features, e.g. a 
helix-turn-helix motif. 
We then sought for experimental data supporting the 
hypothesis that IF2 could be a DNA binding protein. 
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We used gene fusion technology to synthesize an IF2 
C-terminal fragment+galactosidase hybrid protein. 
This fused protein was purified by affinity chromatog- 
raphy. In vitro binding assays performed with various 
DNA fragments howed to assess this hypothesis. 
2. MATERIALS AND METHODS 
2.1. Reagents and materials 
Restriction endonucleases and all DNA modifying enzymes were 
from either Boehringer-Mannheim or Pharmacia and used as directed 
by suppliers. 
2.2. Strain and media 
The E. co/i strain used to express the hybrid protein was SE 5000 
(F-, araD139, Alac169, rpsL, thiA, recA). The strain was grown on 
L-broth [17] and L-broth supplemented with ampicillin (50 ,ug/ml) 
when bearing the plasmid used in this study. 
2.3, IF2 protein 
Purified IF2 protein was kindly provided by S. Laalami (IBPC, 
Paris). A mixture of both forms, IF2a and IF2p, in a ratio of about 
2/l was used in this study. 
2.4. Construction and purification of the fusion protein 
The pGV233-2 vector was constructed from pKK233-2 (purchased 
from Phannacia) as described elsewhere [16] by insertion of IacZ and 
Iacl genes. 
In Fig. 3, the stippled region, in the infB gene, shows the (DraIIIt 
HpaI segment coding for an IF2 peptide encompassing the homolo- 
gous part. The hybrid protein was constructed by isolating the DraIII- 
HpaI fragment from pB16-1. The 3’ over hang DraIII site was digested 
with T4 polymerase and the fragment was then inserted into pGV233- 
2 between NcoI-filled and PvuII. Purification of the fusion protein 
synthesized from pGJ3 (Fig. 3) was performed according to Ullmann 
[18] with previously reported modifications [16] except hat induction 
was realized with only 0.02 mM IPTG over 1 h to avoid formation of 
inclusion bodies. 
2.5. DNA binding assay 
DNA fragments from pJLA501 [19] were labelled by random prim- 
ing using d[a-3ZP]ATP. 
DNA fragments from pKK3535 were labeled by end repairing of 
the BarnHI site by the large fragment of DNA polymerase I using 
d[cc-32P]ATP as the radioactive nucleotide. 
DNA binding was assayed as previously reported [20] except 
that binding buffer was composed as follows: 10 mM Tris-HCI, 
pH 7, 2 mM CaCl*, 0.1 mM EDTA, 50 mM KCl, 5% DMSO, 
100 &ml bovine serum albumin, labelled DNA (lo’-lo* cpm@g) 
2 . lo-‘*-2 . lo-” M. 
The total volume of the reaction was 300 ~1. The mixture was 
incubated at 4°C for 30 min and 280 ~1 of the reaction was loaded on 
nitrocellulose filters (BA85, Schleicher and Schuell) under gentle vac- 
uum. The filters were washed twice with 300 ,~l of cold binding buffer, 
dried and the radioactivity was measured in a scintillation mixture 
(Optiphase, Beckman). 
3. RESULTS 
The region of homology between IF2 and c1 is pre- 
sented in Fig. 1. It extends from Leu709 to GlyszO in IF2, 
corresponding to a segment of c1 from Let?’ to Gly14’ 
[21]. Considering only strictly identical amino acids 
upon sequence alignment, a 31.7% identity score is ob- 
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tained. When substitutions of closely related amino 
acids are taken into account the degree of homology 
reaches 40%. 
The homologous segment of the c1 repressor contains 
the helix-turn-helix motif involved in the binding of the 
repressor to lambda operators OR and OL. It can be seen 
in Fig. 1 that the sequence Gly-Gln-Ser-Gly-Val-Gly of 
c1 helix 3 [22,23] (‘recognition helix’), has a highly con- 
served counterpart in IF2, where Gln is, however, miss- 
ing. 
Amino acids that determine the structure of the hy- 
drophobic core of the repressor have been identified 
previously [24]. Out of 7 buried residues identified in c1, 
6 are located in the homologous region between IF2 and 
c1. Among them, 3 are strictly conserved in IF2 (Va1716, 
Va1725 and L~u’~~) and 2 others (Ile720 and Ser73p, replac- 
ing Met4 and Leu65 in c1, were found in partially func- 
tional c1 mutants. 
Another homologous sequence block appears in the 
Ser783-Lys7gL subdomain in IF2 (corresponding to 
Ala’l’-Arg’lg in cI), which overlaps the RecA cleavage 
site of c1 (Ala111-Glu’12 peptide bond) [25]. IF2 is not 
known to be a target of RecA protein in vivo. 
Another important function of lambda repressor is 
the activation of transcription of its own gene via con- 
tact with the RNA polymerase. The acidic residue G1u34 
seems to play a key role in this process [26] since any 
other residue but an Asp at the same position drastically 
reduces the corresponding position. 
These observations based solely on primary sequence 
analysis are not sufficient per se to demonstrate that IF2 
harbors the structural motifs previously identified in 
lambda c1, particularly the helix-turn-helix motif. 
Therefore, this theoretical study was carried on by cal- 
culation of the distribution of the hydrophobic amino 
acids along the putative helix-turn-helix motif of both 
IF2 and c1 homologous regions. As shown in Fig. 2A 
and B, the overall distribution of hydrophobic residues 
is similar in CI and IF2 homologous regions. This ob- 
servation is consistent with the similarity of the hydro- 
phobicity profiles [27] that is observed in the first two- 
third of the homology (data not shown). 
To experimentally investigate the properties of this 
domain of IF2, we decided to design a strategy that 
potentially allows its isolation from the original context 
in IF2. We therefore subcloned a defined IF2 gene seg- 
ment in an expression vector, in frame with an ATG on 
its 5’ side and the eighth codon and the lad gene on its 
3’ side. 
Fig. 3 shows the construction of that gene fusion (see 
section 2). The infB region fused to lad encompasses 
Va168g-Vals52 and thus is long enough to carry the over- 
all region homologous to c1 (Leu709-Gly820). The result- 
ing gene fusion encodes then for a hybrid protein IF2’- 
/?-galactosidase under the control of the inducible Ptrc 
promoter that can be purified by affinity chromatogra- 
phy [16] (insert in Fig. 3). 
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Fig. 1. Sequence homologies between IF2 and c1. The IF2 amino acid sequence [14] was compared to that for lambda cI[21] and one region of 
homology was detected. Sequence similarity alignments were done in accordance to Beckman Microgenie software. Exact amino acid homologies 
are boxed, near-identical residues are in rounded boxes, and IF2 residues found at the same position in other repressors [30] are underlined. The 
vertical arrow shows the RecA cut site in c1. Residues absent along the IF2 strand are replaced by dashes. 
The primary structural features of the IF2 segment 
homologous to the c1 repressor indicate that this region 
may be implicated in a nucleic acid binding function. 
Among the ligands of IF2 containing nucleic acids 
(rRNA and tRNA initiator), the tRNA initiator may be 
a potential candidate since ribosome-IF2 interaction 
does not seem to involve rRNA [13]. Our attempts to 
measure binding of the hybrid protein with the initiator 
tRNA were unsuccessful (data not shown), under condi- 
tions otherwise allowing an IF2 binding [12]. 
Alternatively, it is also conceivable that this region of 
IF2 could be implicated in DNA binding and activation 
of transcription, a function already suspected [5]. 
To investigate possibility that IF2 had the same target 
DNA, if any, as the c1 repressor, we performed DNA 
binding assays on nitrocellulose filters using two differ- 
ent fragments purified from the plasmid pJLA501 [19]. 
The two fragments differ by the presence or absence of 
the PR promoter. The larger fragment (1.2 kb) carries 
the three 0, target operators of c1, followed by the c1 
gene itself, while the smaller fragment (0.8 kb) carries 
only the truncated c1 gene. 
Results obtained from the 1.2 kb fragment are pre- 
sented on Fig. 4A. IF2 and the hybrid protein exhibit 
a DNA binding activity with this fragment, 8685% of 
DNA is bound with an IF2 concentration of lo-’ M and 
a hybrid protein concentration of 10m6 M, giving an 
apparent _Kd of about 8 . 10e9 to lo-’ M and 3-5.10-* M, 
respectively. In contrast, no binding could be observed 
with /I-galactosidase alone or the IF2 G-domain-p-ga- 
lactosidase hybrid protein under identical conditions. 
DNA binding assays performed with the shorter frag- 
ment result in very similar patterns with the 4 proteins 
(data not shown). Thus, it is likely that (i) IF2 has a 
consistent affinity for DNA, (ii) the IF2-C terminal seg- 
ment fused to p-galactosidase is involved in this DNA 
Fig. 2. Amphiphilic region distribution between IF2 and c1 helix-turn-helix regions. The plots were obtained with the Helicalwheel program from 
the Genetics Computer Group Inc. (Madison, WI, USA) using a rotation angle of 96”. (A) The helical representation extends from Glu”’ to AsrP 
ofc1. (B) The helical representation extends from the corresponding homologous region of IF2, i.e. from ThP to GlP. The boxed residues indicate 
hydrophobic residues. 
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Fig. 3. Schematic map of IF2 and construction of the IF2’-jl-galactosidase hybrid protein. The first amino acid positions of IF2cc and IF@, 1 and 
158, respectively, are also indicated. The cross-hatched region represents the domain of IF2 homologous to lambda c1 repressor (see section 2 for 
details of the fusion gene construct). The filled region represents the G-domain coding part of IF2, extending from Ala39’ to Gly”. The insert shows 
the expression of the hybrid protein in SE5000 E. co/i cells (lane a) and the affinity-purified fusion protein (lane b) analysed by SDS-PAGE and 
stained with Coomassie blue R-250. 
binding property, and (iii) IF2 does not display any 
specific affinity for the P, promoter. 
Previous in vitro experiments [5] report the ability of 
IF2 to activate transcription of the rrnB operon. How- 
ever, it is not clear from this study if a DNA binding 
step, specific or non-specific, is required to activate 
RNA polymerase, or if a protein-protein interaction 
between IF2 and the RNA polymerase is responsible 
and sufficient to provide activation. 
To assess whether the C-terminal domain of IF2 
could interact with upstream regulatory elements of the 
rrnB operon, we analysed IF2 affinity for these up- 
stream sequences. The 7.5 kb BumHI fragment carrying 
the rrnB operon was isolated from the pKK3535 plas- 
mid [28]. This fragment harbors the tandem promoters 
Pl and P2 together with upstream sequences. In con- 
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trast, the 6 kb HindIII-BarnHI fragment lacks this 
proximal part of the operon. 
The incubation of IF2 with the radiolabeled BumHI 
fragment is shown in Fig. 4B. 
The affinity of both IF2 and the fusion protein for the 
rrnB operon is similar, although lower, to the affinity 
observed for the lambda phage fragments. The appar- 
ent & deduced from these data is about 1-2 . lo-* M 
for IF2 and l-2 . lo-? M for the fusion protein. 
Again, IF2 harbors a higher affinity for the DNA 
than the fusion protein and the binding to the DNA is 
specific to the C-terminal domain of IF2. 
By using the HindIII-BumHI fragment a similar pro- 
file is obtained (data not shown), indicating that the 
tandem promoters and the upstream elements of the 
rrnB operon are not specifically bound by IF2. 
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Fig. 4. DNA binding activity of IF2 and purified hybrid protein. (A) 
Incubation of IF2 and the purified hybrid protein with a 1.2 kbp- 
labelled DNA fragment isolated from pJLA503 plasmid (see section 
2). The fragment carries the Pa promoter of lambda phage. (B) Incu- 
bation of the same proteins with a 7.5-kbp-labelled DNA fragment 
isolated from pKK3535 plasmid and carrying the entire rrnB operon. 
Protein-DNA complexes were isolated on nitrocellulose filters. The 
radioactivity was determined by scintillation counting. Both IF2 (0) 
and the hybrid protein (0) show a consistent non-specific DNA bind- 
ing activity, although the fusion protein displays a lower affinity (see 
text). In contrast, /I-galactosidase (A) or a hybrid IF2 G-domain-p- 
galactosidase protein [16] (A) did not bind to DNA. The 100% value 
corresponds to the binding of about l-5 fmol of labelled DNA. Each 
point represents the average of two independent experiments. 
4. DISCUSSION 
Our results support the evidence that IF2 can also 
display a DNA binding activity mediated by a C-termi- 
nal domain homologous to the c1 repressor of lambda 
phage. 
The IF2 homologous domain shows a conservation 
of several important residues of the c1 repressor (Fig. 
l), such as residues essential for hydrophobic core sta- 
bility, indicating that the IF2 domain could display a 
similar structure. Computational analyses are necessary 
to verify the structure of IF2 in this part of the protein. 
Crystallographic data obtained with the c1 repressor 
may be used to build a computer model, as already 
realized for the IF2 G domain [l 11. 
Although the first segment of c1 recognition helix 3 
(Ser-Gly-Val-Gly) is well conserved in IF2, the absence 
in IF2 of other important amino acids, which partici- 
pate or cooperate to the recognition of specific bases by 
c1 [23], indicates that the DNA recognition specificity 
of IF2 should differ from that of c1. 
In order to analyze the DNA binding properties of 
the IF2 domain, an infB fragment encompassing this 
domain was fused to the /I-galactosidase gene. The puri- 
fied hybrid protein was used in nitrocellulose filtration 
assays. Our results confirm the hypothesis that IF2 and 
c1 harbor different specificities. 
Similar experiments performed with rrnB operon 
fragments lead to the conclusion that these rrnB up- 
stream sequences are also not specifically recognized in 
vitro by IF2. However, it is important to note here that 
in vitro transcription activation of the rrnB operon oc- 
curs only at low ionic strength, i.e. KC1 concentrations 
lower than 10 mM. Higher KC1 concentrations (50 mM 
up to 100 mM) were used in our assays to ensure that 
binding was not a consequence of non-specific interac- 
tions between DNA and proteins. Furthermore, it was 
concluded, based on sedimentation experiments [5], that 
IF2 must be present prior to the initiation of transcrip- 
tion and influences the formation of the transcription 
initiation complexes. Since IF2 does not induce tran- 
scriptional activation from other promoters, the IF2 
molecule is probably the selective component of the 
binary complex RNA polymerase-IF2 required to se- 
lectively activate the rrnB operon. Therefore it is possi- 
ble that only the RNA polymerase-IF2 complex is ca- 
pable of binding and specifically activating the ribo- 
somal operon. The DNA binding activity of both IF2 
and the fusion protein indicates that the C-terminal 
domain could be involved in this transcription activa- 
tion process and the conservation of the acidic residue 
Asp714, could indicate that this activation would occur 
by contact between this same domain of IF2 and RNA 
polymerase. 
The fact that a IMet-ARNtrMet-hybrid protein bind- 
ing was not observed under our experimental conditions 
does not imply that the fused IF2 domain is exclusively 
implicated in a DNA binding function. Indeed, it could 
possibly be involved in at least two cellular processes: 
initiation of protein synthesis via fMet-ARNtr”“’ bind- 
ing, and activation of transcription, via DNA binding. 
In the same way, one can note that fMet-tRNAr”” 
binds in a highly specific fashion to polymerase holoen- 
zyme [29]. 
During rapid exponential growth, E. coli produces no 
more ribosomes than are required for protein synthesis 
[30]. One hypothesis proposes that transcription and 
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translation are coupled by the factors involved in trans- 
lation [31]. EF-TuTs [31] and fMet-tRNAr”“’ [29] alter 
transcription selectivity in vitro. 
One can imagine that the IF2 level regulates both 
initiation of protein synthesis and activation of tran- 
scription of ribosomal operon(s). According to this hy- 
pothesis, since the IF2 concentration in the cell is con- 
stant (lO-‘j M) [2], a low concentration of free IF2, 
occurring under high protein synthesis activity, could 
lead to activation of rDNA transcription. In contrast, 
high levels of rRNA would induce the dominant nega- 
tive feedback control described before [32-341. 
Our next goal will be to determine the DNA target 
sequence, if any, specifically recognized by the C-termi- 
nal IF2 domain. This could be achieved by rounds of 
incubation of IF2 with random sequence oligonucleo- 
tides and PCR amplification of the bound DNA, as 
already described [35]. Mutagenesis of conserved IF2 
residues that are functionally important in the c1 re- 
pressor will also be helpful to investigate the role of this 
domain of IF2 in E. coli infB mutants [lo]. 
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